{"nct_id":"NCT05966480","title":"Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2023-06-26","start_date_type":"ACTUAL","primary_completion_date":"2026-07-01","primary_completion_date_type":"ESTIMATED","completion_date":"2027-09-01","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["ALMS"]}